Abstract:Vascular dementia (VaD) is recognised as a neurocognitive disorder, which is explained by numerous vascular causes in the general absence of other pathologies. The heterogeneity of cerebrovascular disease makes it challenging to elucidate the neuropathological substrates and mechanisms of VaD as well as vascular cognitive impairment (VCI). Consensus and accurate diagnosis of VaD relies on wide-ranging clinical, neuropsychometric and neuroimaging measures with subsequent pathological confirmation. Pathological diagnosis of suspected clinical VaD requires adequate postmortem brain sampling and rigorous assessment methods to identify important substrates. Factors that define the subtypes of VaD include the nature and extent of vascular pathologies, degree of involvement of extra and intracranial vessels and the anatomical location of tissue changes. Atherosclerotic and cardioembolic diseases appear the most common substrates of vascular brain injury or infarction. Small vessel disease characterised by arteriolosclerosis and lacunar infarcts also causes cortical and subcortical microinfarcts, which appear to be the most robust substrates of cognitive impairment. Diffuse WM changes with loss of myelin and axonal abnormalities are common to almost all subtypes of VaD. Medial temporal lobe and hippocampal atrophy accompanied by variable hippocampal sclerosis are also features of VaD as they are of Alzheimer’s disease. Recent observations suggest that there is a vascular basis for neuronal atrophy in both the temporal and frontal lobes in VaD that is entirely independent of any Alzheimer pathology. Further knowledge on specific neuronal and dendro-synaptic changes in key regions resulting in executive dysfunction and other cognitive deficits, which define VCI and VaD, needs to be gathered. Hereditary arteriopathies such as cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy or CADASIL have provided insights into the mechanisms of dementia associated with cerebral small vessel disease. Greater understanding of the neurochemical and molecular investigations is needed to better define microvascular disease and vascular substrates of dementia. The investigation of relevant animal models would be valuable in exploring the pathogenesis as well as prevention of the vascular causes of cognitive impairment.

Pathological changes in neurovascular units: Lessons from cases of vascular dementia

Cerebral small vessel disease alters neurovascular unit regulation of microcirculation integrity involved in vascular cognitive impairment

Cerebral Microvascular Dysfunction and Neurodegeneration in Dementia

Roles of neurovascular unit in cognitive impairment induced by chronic cerebral hypoperfusion

Dysfunction of Cerebrovascular Endothelial Cells: Prelude to Vascular Dementia

Dissecting the neurovascular unit in physiology and Alzheimer's disease: Functions, imaging tools and genetic mouse models

Progression in Vascular Cognitive Impairment: Pathogenesis, Neuroimaging Evaluation, and Treatment

The impact of cerebrovascular aging on vascular cognitive impairment and dementia

Vascular Contributions to Healthy Aging and Dementia

Dysfunction of the neurovascular unit in ischemic stroke and neurodegenerative diseases: An aging effect

Progression in Vascular Cognitive Impairment: Pathogenesis, Neuroimaging Evaluation, and Treatment.

Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders

The Pathobiology of Vascular Dementia

Vascular cognitive impairment: Advances in clinical research and management.

Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer’s disease

The Chronic Cerebral Hypoperfusion Hypothesis

Vascular Dementia: A Microglia's Perspective.

Vascular cognitive impairment and dementia: Mechanisms, treatment, and future directions

The cognitive and neuropsychiatric changes in vascular dementia by lacunar infarction

Endothelial Dysfunction in Neurodegenerative Diseases

The Neurovascular Unit Dysfunction in Alzheimer’s Disease